LyrArc Article Gist
Lobbying by the pharmaceutical and health care industry and U.S. president Obama's promises to the industry as part of his shaping the health care law.

LyrArc Article Gist
Abbott's decision to raise the price of AIDS drug Norvir 5 fold in 2003, and how it undercut Glaxo's drug Lexiva which is used in combination with Norvir. Abbott included Norvir ingredients in a new drug Kaletra and this was priced cheaper than other AIDS drugs when it increased the price of Norvir. Glaxio is now suing Abbott for this pricing practice.

LyrArc Article Gist
Glaxo spent $279 million in the first half of 2008, second only to Pfizer's 462 million. Much of this is televison advertising, which has come under criticism for exaggerating the benefits of drugs and minimizing the risks. Television advertising for prescription drugs is banned in most countries, except for the USA and New Zealand. Now Glaxo CEO, Witty says, Glaxo will do less television advertising than in the past.

LyrArc Article Gist
Blackberry maker Research In Motion's will introduce new products to prevent further erosion of market share. Five new smartphones will be introduced, including an all touch screen phone to compete with the iPhone. Smartphones using its new QNX software will not be available till 2012. Meanwhile Apple is bringing out a new version of the iPhone and new smartphone are being released by competitors. RIM's share of global smartphones is down to 12.9% for the 1st quarter of 2011, compared to 19.7% the prior year. In the N. American market RIM's market share for smartphones is down to 16.5%, a big decline from 41.3% in the first quarter of 2010. Missed deadlines for new products are a major problem for RIM in the fast paced environment for new technologies and software with new competitors from related fields.

LyrArc Article Gist
Experts say Chief Justice Roberts somehow found a path through in bridging the ideological divide and avoiding a show of partisanship in an election year. He somehow navigated and found a path through in his vote on the U.S. healthcare law letting it stand. Early on Roberts advocated "judicial modesty and humility" in jurisprudence. He compared the judge's role to that of an umpire in baseball during the 2005 confirmation hearings. The umpire would not pitch or bat, his job would be to call balls and strikes. It was seen as a determmined show of independence at a time when Justice Kennedy was seen as the swing vote. He has also earned political capital to be able to vote independently on other issues before the court instead of becoming embroiled in controversy about the role of the Court in overturning the work of Congress during the early part of the Obama administration.

LyrArc Article Gist
A health care practitioner says the real problem is the high cost of medical care in the U.S. when compared to other countries. She points out that the Obama bill in 2008 did not take effective steps to bring down the cost of health care before enacting legislation to cover the uninsured, leading to higher premiums for the middle class. The link between healthcare and profits is seen as the main problem. 

LyrArc Article Gist
The way a number of lawsuits and a antitrust investigation turn out about whether Abbott violated antitrust laws in efforts to prevent an Israeli company selling a generic version of Aboots drug for cholesterol called Tricor, will say a lot about how far drug companies can go in fighting generic versions coming from competitors.

LyrArc Article Gist
Serious issues with China's export of drug and food related items. The same is true for the domestic use of drugs and food which has been contaminated by hazardous chemicals. Zheng eas head of China's FDA from 1998 to 2005. China is reviewing some 170,000 production licenses issued during this period.

LyrArc Article Gist
Elizabeth Rosenthal looks at Obamacare's contribution to cost containment in 2013-2014. Rosenthal says its is a kind of delicate maneuvring at the edges, because serious work needs to be done. The fee-for-service and many of the drivers for increases in medical costs, the old system of pricing, are still in place. In 20 years at the current rate and after Obamacare health care will still take 25% of the U.S. budget if nothing is done. Healthcare costs are about half that of the U.S. in some of the advanced European countries. She calls Obamacare a trickle down theory of cost containment becaue it leaves most of the drivers for cost increase in place and works at the margins. Princeton economist Uwe Reinhardt calls it an ugly patch on a somewhat ugly system. Rosenthal cites the armies of consultants anticipating every move to reduce prices, and working on "strategic billing'' to increase revenues for hospitals and doctors. For those who say the prices are now up more slowly than in the past, Michael Chernew of the Harvard Medical School, has this to say- its like a diet, reminding us that that we haven't even lost weight, just gaining weight slower than before. ...